KJZZ is a service of Rio Salado College, and Maricopa Community Colleges
Privacy Policy | FCC Public File | Contest Rules
Copyright © 2024 KJZZ/Rio Salado College/MCCCD
Play Live Radio
Next Up:
0:00 0:00
Available On Air Stations

Analysis: Patient-therapist bond may be key to treating depression with 'magic mushrooms'

Arizona’s advisory council on psilocybin research is soon expected to release a draft report about psychedelic-assisted therapy.

Researchers at Ohio State University say a provider-patient bond may matter most when treating depression with psychedelic mushrooms.

Ohio State researchers analyzed data gathered from a 2021 clinical trial that found psilocybin combined with therapy was effective at treating depression.

They concluded that the stronger the relationship between participant and therapist, the lower the participant’s depression score was one year later.

Arizona lawmakers set aside $5 million last year to study if psychedelic mushrooms can help people with pain, addiction and PTSD.

Research grants have been approved. But the money is unlikely to be spent before July, when the state can claw it back.

Matthew Casey has won Edward R. Murrow awards for hard news and sports reporting since he joined KJZZ as a senior field correspondent in 2015.